Sotera Health (SHC) EV/EBITDA Multiple

Sterigenics - graphic logo of issuer SHC

Sotera Health Company (SHC) has achieved deep integration into pharmaceutical manufacturing cycles, maintaining a monopoly status. The EV/EBITDA multiple dynamics for this heavy-duty business visualize this success, where 11.34 indicates the current level. Stability is ensured by strict sterilization regulations, which create client dependency. Additionally, the business relies on a lack of seasonality and cyclicality, operating independently of economic fluctuations.

SHC Sterigenics: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 11/14/2026

SHC (soterahealth.com): analytical breakdowns and indicator data

- market price and analyst price targets:
Price Chart Sterigenics|SHC - Analyst Median Target
- market capitalization details:
Market Capitalization Nordion|SHC - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Sotera Health|SHC - Book Valuation of Business|Market Value to Book Value Ratio soterahealth.com|SHC - Company Total Asset Base
- company liabilities and liquidity data:
Debt to Equity Sotera Health Company|SHC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Sotera Health|SHC - Company Cumulative Indebtedness|Debts to Book Capitalization Nordion|SHC - Long-Term Debt|Company Short-Term Debt Sotera Health|Quick Ratio soterahealth.com
- business earnings and investment ratios data:
SHC - Net Profit|Future Profit Sotera Health Company|SHC - Company Value to Net Income|Forward P/E Multiple Sotera Health Company|SHC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Nordion|SHC - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Sotera Health|SHC - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months soterahealth.com|SHC - Earnings per share growth in current year|Expected earnings per share growth for next year Sotera Health Company
- sales volume and revenue indicators:
SHC - Company Total Sales|Projected Sales Volume Sterigenics|SHC - Market Capitalization-to-Revenue Ratio|Forward Price-to-Revenue Multiple Nordion
General company analysis:Sterigenics SHC
Original product of Sotera Health Corp

This indicator reflects the enterprise value relative to operating profit, allowing for an assessment of the real value of assets without the impact of taxes and depreciation. By analyzing the EV/EBITDA trend of Sotera Health Company (SHC), an investor can gauge the margin resilience of its sterilization and testing services amid inflationary pressure on costs and payroll.

Competitor analysis

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agilent Tech A|Total Company Value to Operating Income Before Depreciation Ratio Quest Corp (DGX)|Illumina, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|Revvity (RVTY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|QuidelOrtho Inc. (QDEL) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPKO Health, Inc. (OPK)|CDNA - Company Value to EBITDA|Maravai LifeSciences Holdings, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio FLGT (Fulgent Genetics Inc)|Fluidigm - EV/EBITDA Multiple|Company Value to EBITDA Cytek Corp|OraSure Technologies (OSUR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Exagen - Business Value to Operating Income Before Depreciation|MDXH (MDxHealth) - EV/EBITDA Multiple|EV/EBITDA Multiple Lucid Diagnostics, Inc.|Enterprise Value to EBITDA Ratio PRE (Prenetics Global)|IMDX (imdxinc.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple TRIB (Trinity Biotech)|Business Value to Operating Income Before Depreciation PRPH|Ainos - EV/EBITDA Multiple|Company Value to EBITDA Co-Diagnostics Inc|HSCS: EV/EBITDA Multiple|Biomerica Inc (BMRA) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cardio Diagnostics Holdings Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ONCO|Enterprise Value to EBITDA Ratio VRAX (Virax Biolabs)|Enterprise Value to Operating Income Before Depreciation Ratio BJDX|EV/EBITDA Multiple AWH (Vermillion)|Business Value to Operating Income Before Depreciation AXDX|CNTG: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ENZ (Enzo Biochem, Inc.)|FRES: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Genetic Technologies Limited|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Inc.|Company Value to EBITDA Psychemedics Inc PMD